Effect of diabetes mellitus on protein-energy wasting and protein wasting in end-stage renal disease
- PMID: 20525107
- DOI: 10.1111/j.1525-139X.2010.00705.x
Effect of diabetes mellitus on protein-energy wasting and protein wasting in end-stage renal disease
Abstract
Protein wasting (PW) or protein-energy wasting (PEW) occurs commonly in patients with diabetes mellitus who have end-stage renal disease (ESRD) and are undergoing maintenance dialysis (MD) therapy. Some but not all studies indicate that PW or PEW is more prevalent in diabetic when compared with nondiabetic MD patients and that diabetic patients commencing maintenance hemodialysis (MHD) are more likely to lose fat-free, edema-free weight than are incident nondiabetic MHD patients. The causes of PW and PEW in diabetic MD patients are probably largely similar to those of nondiabetic MD patients. These causes include anorexia, reduced food intake, concurrent illnesses particularly when associated with inflammatory processes, physical or mental debility, removal of nutrients by dialysis procedure, acidemia, possibly physical deconditioning, and oxidant and carbonyl stress. However, diabetic MD patients are also at greater risk for PW or PEW from comorbidities related to diabetes per se. These disorders include ischemic vascular disease, hypertension, gastrointestinal dysfunction, and neuropathy. Metabolic disorders such as insulin deficiency or resistance to the actions of insulin, and elevated levels of counterregulatory hormones may also contribute to PW or PEW in diabetic MD patients. Mechanisms by which these metabolic disorders in diabetic ESRD patients may cause PW or PEW are discussed.
Similar articles
-
Causes and prevention of protein-energy wasting in chronic kidney failure.Semin Nephrol. 2009 Jan;29(1):39-49. doi: 10.1016/j.semnephrol.2008.10.006. Semin Nephrol. 2009. PMID: 19121473
-
Pathophysiology of protein-energy wasting in chronic renal failure.J Nutr. 1999 Jan;129(1S Suppl):247S-251S. doi: 10.1093/jn/129.1.247S. J Nutr. 1999. PMID: 9915908 Review.
-
Assessment of methods to identify protein-energy wasting in patients on hemodialysis.J Bras Nefrol. 2011 Mar;33(1):55-61. J Bras Nefrol. 2011. PMID: 21541464 English, Portuguese.
-
Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients.Nephrol Dial Transplant. 2008 Sep;23(9):2957-64. doi: 10.1093/ndt/gfn167. Epub 2008 Apr 9. Nephrol Dial Transplant. 2008. PMID: 18400817
-
Effect of kidney failure and hemodialysis on protein and amino acid metabolism.Curr Opin Clin Nutr Metab Care. 2012 Jan;15(1):78-84. doi: 10.1097/MCO.0b013e32834d9df6. Curr Opin Clin Nutr Metab Care. 2012. PMID: 22108097 Review.
Cited by
-
Transthyretin predicts cardiovascular outcome in hemodialysis patients with type 2 diabetes.Diabetes Care. 2012 Nov;35(11):2365-72. doi: 10.2337/dc12-0455. Epub 2012 Aug 24. Diabetes Care. 2012. PMID: 22923667 Free PMC article.
-
Angiotensin II receptor blockade is associated with preserved muscle strength in chronic hemodialysis patients.BMC Nephrol. 2019 Feb 14;20(1):54. doi: 10.1186/s12882-019-1223-3. BMC Nephrol. 2019. PMID: 30764799 Free PMC article.
-
A prospective cohort study of risk prediction in simultaneous pancreas and kidney transplantation.Ann R Coll Surg Engl. 2015 Sep;97(6):445-50. doi: 10.1308/rcsann.2015.0001. Epub 2015 Aug 14. Ann R Coll Surg Engl. 2015. PMID: 26274754 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical